PL

Paola LaColla

CN CNRS: 8 patents #159 of 11,908Top 2%
IP Idenix Pharmaceuticals: 8 patents #16 of 67Top 25%
UC Università Degli Studi Di Cagliari: 6 patents #4 of 61Top 7%
LI L'Universite Montpellier Ii: 4 patents #6 of 12Top 50%
📍 Cagliari, IT: #2 of 68 inventorsTop 3%
Overall (All Time): #656,592 of 4,157,543Top 20%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
7662798 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Jean-Pierre Sommadossi, Gilles Gosselin 2010-02-16
7635689 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Richard Storer, Gilles Gosselin, Jean-Pierre Sommadossi 2009-12-22
7625875 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Gilles Gosselin, Richard Storer, Jean-Pierre Sommadossi 2009-12-01
7608600 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Richard Storer, Gilles Gosselin, Jean-Pierre Sommadossi 2009-10-27
7547704 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Richard Storer, Gilles Gosselin, Jean-Pierre Sommadossi 2009-06-16
7384924 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Richard Storer, Gilles Gosselin, Jean-Pierre Sommadossi 2008-06-10
7365057 Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections Richard Storer, Gilles Gosselin, Jean-Pierre Sommadossi 2008-04-29
7192936 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Richard Storer, Gilles Gosselin, Jean-Pierre Sommadossi 2007-03-20